Communication of launch prices by drug companies, 2022-2024.

Reid B, Cohen JT, Lin PJ, Neumann PJ

DOI: 10.37765/ajmc.2025.89838
Published: 2025 Dec 1
Container: The American journal of managed care
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.37765/ajmc.2025.89838,
  title = {Communication of launch prices by drug companies, 2022-2024.},
  author = {Reid B and Cohen JT and Lin PJ and Neumann PJ},
  year = {2025},
  journal = {The American journal of managed care},
  doi = {10.37765/ajmc.2025.89838},
  url = {https://doi.org/10.37765/ajmc.2025.89838}
}

RIS

TY  - JOUR
TI  - Communication of launch prices by drug companies, 2022-2024.
AU  - Reid B
AU  - Cohen JT
AU  - Lin PJ
AU  - Neumann PJ
PY  - 2025
JO  - The American journal of managed care
DO  - 10.37765/ajmc.2025.89838
UR  - https://doi.org/10.37765/ajmc.2025.89838
ER  -

APA

B, R., JT, C., PJ, L., & PJ, N. (2025). Communication of launch prices by drug companies, 2022-2024.. The American journal of managed care. https://doi.org/10.37765/ajmc.2025.89838

Source records

pubmed · retrieved 2026-09-25T01:52:17.499Z